We are live on
!
Find out more
RG
Redmile Group Portfolio holdings
AUM
$1.51B
1-Year Est. Return
164.17%
This Fund
S&P 500
This Quarter
Est. Return
-13.65%
1 Year Est. Return
+164.17%
3 Year Est. Return
+929.47%
5 Year Est. Return
+823.75%
10 Year Est. Return
+18,826.17%
AUM
$2.62B
AUM Growth
-$585M
(-18%)
Cap. Flow
+$149M
Cap. Flow
% of AUM
5.7%
Top 10 Holdings %
Top 10 Hldgs %
51.83%
Holding
74
New
4
Increased
19
Reduced
26
Closed
3
Top Buys
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$86.5M |
| 2 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$59.5M |
| 3 |
Xenon Pharmaceuticals
XENE
|
+$49.6M |
| 4 |
MDVL
MedAvail Holdings, Inc. Common Stock
MDVL
|
+$24.8M |
| 5 |
BioMarin Pharmaceuticals
BMRN
|
+$23.9M |
Top Sells
| 1 |
argenx
ARGX
|
+$41.9M |
| 2 |
UnitedHealth
UNH
|
+$27.3M |
| 3 |
LivaNova
LIVN
|
+$24.6M |
| 4 |
ICU Medical
ICUI
|
+$21.6M |
| 5 |
SLGC
SomaLogic, Inc. Class A Common Stock
SLGC
|
+$10.8M |
Sector Composition
| 1 | Healthcare | 96.11% |
| 2 | Consumer Staples | 2.55% |
| 3 | Industrials | 0.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
VERV
26
DELISTED
Verve Therapeutics
VERV
| $28M | 1.07% |
1,833,547
-1,781
| -0.1% | -$27.6K |
|
27
Absci
ABSI
$1.67B
| $26.7M | 1.02% |
8,031,094
| – | – |
|
28
Stoke Therapeutics
STOK
$1.87B
| $26.3M | 1.01% |
1,993,268
-31,100
| -2% | -$472K |
|
|
AUGX
29
DELISTED
Augmedix, Inc. Common Stock
AUGX
| $25.9M | 0.99% |
14,380,327
| – | – |
|
|
30
BioMarin Pharmaceuticals
BMRN
$11.4B
| $24.9M | 0.95% |
+300,000
| New | +$23.9M |
|
31
Pliant Therapeutics
PLRX
$68.7M
| $24.6M | 0.94% |
3,069,001
-11,800
| -0.4% | -$75.6K |
|
32
Entrada Therapeutics
TRDA
$269M
| $23.8M | 0.91% |
1,954,419
| – | – |
|
33
Shattuck Labs
STTK
$607M
| $22.8M | 0.87% |
5,619,914
| – | – |
|
|
OSH
34
DELISTED
Oak Street Health, Inc.
OSH
| $22.7M | 0.87% |
1,383,619
+180,000
| +15% | +$3.5M |
|
35
Zymeworks
ZYME
$1.81B
| $20.3M | 0.78% |
3,835,818
+1,721,621
| +81% | +$10.4M |
|
36
Prothena Corp
PRTA
$449M
| $20M | 0.76% |
736,175
| – | – |
|
|
DCPH
37
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $18.8M | 0.72% |
1,430,917
+766,100
| +115% | +$8.46M |
|
38
Scholar Rock
SRRK
$6.45B
| $18.7M | 0.71% |
3,403,926
+996,600
| +41% | +$7.16M |
|
|
NVRO
39
DELISTED
NEVRO CORP.
NVRO
| $17.8M | 0.68% |
405,517
-5,500
| -1% | -$302K |
|
40
Stevanato
STVN
$5.4B
| $17.6M | 0.67% |
1,115,825
-34,400
| -3% | -$568K |
|
|
GRTS
41
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
| $16.8M | 0.64% |
6,952,760
+81,022
| +1% | +$213K |
|
|
AKRO
42
DELISTED
Akero Therapeutics
AKRO
| $15M | 0.57% |
1,587,285
-15,000
| -0.9% | -$156K |
|
|
RAPT
43
DELISTED
RAPT Therapeutics
RAPT
| $14.9M | 0.57% |
102,229
+8,644
| +9% | +$1.15M |
|
|
ISEE
44
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $14.6M | 0.56% |
1,518,900
+33,100
| +2% | +$415K |
|
45
Jazz Pharmaceuticals
JAZZ
$15.1B
| $14.6M | 0.56% |
93,264
-21,500
| -19% | -$3.31M |
|
46
Annexon
ANNX
$957M
| $13.2M | 0.5% |
3,503,190
+300,273
| +9% | +$917K |
|
47
Nuvation Bio
NUVB
$2.03B
| $11.2M | 0.43% |
3,471,709
| – | – |
|
48
Tandem Diabetes Care
TNDM
$1.06B
| $11.1M | 0.42% |
187,460
-83,758
| -31% | -$6.88M |
|
|
SLGC
49
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
| $9.44M | 0.36% |
2,088,639
-1,818,131
| -47% | -$10.8M |
|
|
NVTA
50
DELISTED
Invitae Corporation
NVTA
| $9.29M | 0.35% |
3,805,403
| – | – |
|
Similar funds
ORI
GAI
HCMG
FMI
FCM
PP
AM
BFO